<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02057510</url>
  </required_header>
  <id_info>
    <org_study_id>12-040-E</org_study_id>
    <secondary_id>1U01DE022939-01</secondary_id>
    <nct_id>NCT02057510</nct_id>
  </id_info>
  <brief_title>Observational Study of Dental Outcomes in Head and Neck Cancer Patients</brief_title>
  <acronym>ORARAD</acronym>
  <official_title>Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Atrium Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Dental and Craniofacial Research (NIDCR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Minnesota</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>UConn Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of North Carolina</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Atrium Health</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to measure the two-year rate of tooth loss in patients who have&#xD;
      received external beam radiation therapy with curative intent for head and neck cancer. The&#xD;
      study will also evaluate the sequelae of radiation therapy and oral complications that may&#xD;
      occur as a result to receiving radiation therapy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective cohort study to document dental and other oral outcomes in patients who&#xD;
      receive external beam radiation therapy with curative intent, as part of clinical care for a&#xD;
      head and neck cancer. Five hundred and seventy-five participants will be enrolled. All study&#xD;
      participants will receive a baseline oral examination prior to the start of radiation&#xD;
      therapy. Follow-up examinations and data collection will be conducted at six-month intervals&#xD;
      up to 2 years after the start of radiation therapy. The primary outcome will be the two-year&#xD;
      rate of tooth loss. Secondary outcomes will include measures of dental caries, periodontal&#xD;
      health, salivary flow, and exposed bone/osteoradionecrosis.&#xD;
&#xD;
      The proposed research will provide more information to inform the community about the&#xD;
      sequelae of Radiation Therapy (RT) in head and neck cancer patients, to refine current&#xD;
      guidelines and to design future studies on the dental management of these patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">June 30, 2024</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2024</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>24 Months</target_duration>
  <primary_outcome>
    <measure>Tooth loss</measure>
    <time_frame>Two Years</time_frame>
    <description>The primary outcome measure is the two-year rate of tooth loss in patients who have received at least one session of external beam radiation therapy with curative intent for head and neck cancer.&#xD;
&quot;Tooth loss&quot; will be defined as a dental extraction that has been performed or recommended. Since dental extractions are often avoided in this population because of the increased risk of osteoradionecrosis (ORN), tooth loss will also include teeth having a dental procedure to avoid extraction of a tooth that would otherwise have been extracted if the individual had not received RT and teeth recommended for extraction that have not been treated. The following categories will constitute teeth that would otherwise be recommended for extraction:&#xD;
non-restorable because of fracture or extent of caries;&#xD;
amputated crown with root remaining;&#xD;
uncontrolled or persistent periodontal or odontogenic infection.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of exposed intraoral bone</measure>
    <time_frame>Two Years</time_frame>
    <description>Two year incidence of exposed intraoral bone, suggestive of ORN. This will be defined as exposed maxillary or mandibular bone with an avascular appearance in a quadrant that has received RT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Extraction complications</measure>
    <time_frame>Within 14 days following procedure</time_frame>
    <description>Incidence of post-extraction complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Decayed, Missing or Filled Surfaces (DMFS) Index</measure>
    <time_frame>Baseline, 24 months</time_frame>
    <description>Two year change in DMFS - Decayed, Missing or Filled Surfaces Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Periodontal Measures</measure>
    <time_frame>Baseline, 24 months</time_frame>
    <description>Two year change in periodontal measures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stimulated Salivary Flow Rate</measure>
    <time_frame>Baseline, 18 months</time_frame>
    <description>18 month changes in stimulated whole salivary flow rates</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Trismus measure</measure>
    <time_frame>Baseline, 24 months</time_frame>
    <description>Two year change in mouth opening in mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Topical fluoride use for caries prevention</measure>
    <time_frame>Baseline, 24 months</time_frame>
    <description>Two year use of fluoride to prevent new caries</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chronic Oral Mucositis Incidence</measure>
    <time_frame>Baseline, 24 months</time_frame>
    <description>Two year chronic oral mucositis incidence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life after Radiation Therapy</measure>
    <time_frame>Baseline, 24 months</time_frame>
    <description>Two year change in radiation therapy-specific quality of life measures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oral Cancer Pain Scale</measure>
    <time_frame>Baseline, 24 months</time_frame>
    <description>Two year change in pain scores as measured with the University of California at San Francisco (UCSF) oral cancer pain scale</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">575</enrollment>
  <condition>Head and Neck Cancer</condition>
  <condition>Dental Disease</condition>
  <condition>Xerostomia</condition>
  <condition>Osteoradionecrosis</condition>
  <arm_group>
    <arm_group_label>Patients receiving head and neck RT</arm_group_label>
    <description>No intervention</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Head and Neck Radiation Oncology patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged 18 years and older;&#xD;
&#xD;
          -  Willing and able to provide signed and dated consent form;&#xD;
&#xD;
          -  Diagnosed with head and neck squamous cell carcinoma (SCC) or a salivary gland cancer&#xD;
             (SGC), and intends to receive external beam radiation therapy (RT) with curative&#xD;
             intent (tumor eradication), with or without concomitant chemotherapy;&#xD;
&#xD;
        OR&#xD;
&#xD;
          -  Diagnosed with a non-SCC, non-SGC malignancy of the head and neck region, and intends&#xD;
             to receive RT, with or without concomitant chemotherapy. The subject must be expected&#xD;
             to receive at least 4500 cGy to one of the following sites:&#xD;
&#xD;
               1. base of tongue&#xD;
&#xD;
               2. buccal/labial mucosa&#xD;
&#xD;
               3. epiglottis&#xD;
&#xD;
               4. floor of mouth&#xD;
&#xD;
               5. gingiva/alveolar ridge&#xD;
&#xD;
               6. hard palate&#xD;
&#xD;
               7. hypopharynx&#xD;
&#xD;
               8. larynx&#xD;
&#xD;
               9. lip&#xD;
&#xD;
              10. mandible&#xD;
&#xD;
              11. maxilla&#xD;
&#xD;
              12. maxillary sinus&#xD;
&#xD;
              13. nasal cavity&#xD;
&#xD;
              14. nasopharynx&#xD;
&#xD;
              15. neck&#xD;
&#xD;
              16. oral cavity&#xD;
&#xD;
              17. oral tongue&#xD;
&#xD;
              18. oropharynx&#xD;
&#xD;
              19. paranasal sinus/orbit&#xD;
&#xD;
              20. parotid gland&#xD;
&#xD;
              21. pharynx&#xD;
&#xD;
              22. retromolar trigone&#xD;
&#xD;
              23. soft palate&#xD;
&#xD;
              24. sublingual gland&#xD;
&#xD;
              25. submandibular gland&#xD;
&#xD;
              26. tonsil;&#xD;
&#xD;
          -  At least 1 natural tooth remaining or expected to remain in the mouth after completion&#xD;
             of the pre-RT dental extractions, if any;&#xD;
&#xD;
          -  Willing to comply with all study procedures;&#xD;
&#xD;
          -  Willing to participate for the duration of the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Receiving palliative RT;&#xD;
&#xD;
          -  History of prior curative RT to the head and neck region to eradicate a malignancy;&#xD;
&#xD;
          -  Incarcerated at time of screening;&#xD;
&#xD;
          -  Anything that would place the subject at increased risk or preclude the subject's full&#xD;
             compliance with or completion of the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael T Brennan, DDS, MHS</last_name>
    <role>Study Chair</role>
    <affiliation>Atrium Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rajesh Lalla, DDS, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Connecticut Health Center - School of Dental Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Connecticut Health Center - School of Dental Medicine</name>
      <address>
        <city>Farmington</city>
        <state>Connecticut</state>
        <zip>06030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New York University - College of Dentistry</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of North Carolina - School of Dentistry</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolinas Medical Center - Dental Clinic</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania - School of Dental Medicine</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Brennan MT, Treister NS, Sollecito TP, Schmidt BL, Patton LL, Mohammadi K, Long Simpson L, Voelker H, Hodges JS, Lalla RV. Dental disease before radiotherapy in patients with head and neck cancer: Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients. J Am Dent Assoc. 2017 Dec;148(12):868-877. doi: 10.1016/j.adaj.2017.09.011. Erratum in: J Am Dent Assoc. 2018 Feb;149(2):89.</citation>
    <PMID>29173331</PMID>
  </results_reference>
  <results_reference>
    <citation>Lalla RV, Treister N, Sollecito T, Schmidt B, Patton LL, Mohammadi K, Hodges JS, Brennan MT; OraRad Study Group. Oral complications at 6 months after radiation therapy for head and neck cancer. Oral Dis. 2017 Nov;23(8):1134-1143. doi: 10.1111/odi.12710. Epub 2017 Aug 3.</citation>
    <PMID>28675770</PMID>
  </results_reference>
  <results_reference>
    <citation>Lalla RV, Long-Simpson L, Hodges JS, Treister N, Sollecito T, Schmidt B, Patton LL, Brennan MT; OraRad Study Group. Clinical registry of dental outcomes in head and neck cancer patients (OraRad): rationale, methods, and recruitment considerations. BMC Oral Health. 2017 Feb 27;17(1):59. doi: 10.1186/s12903-017-0344-y.</citation>
    <PMID>28241807</PMID>
  </results_reference>
  <results_reference>
    <citation>Brennan MT, Treister NS, Sollecito TP, Schmidt BL, Patton LL, Yang Y, Lin A, Elting LS, Hodges JS, Lalla RV. Epidemiologic factors in patients with advanced head and neck cancer treated with radiation therapy. Head Neck. 2021 Jan;43(1):164-172. doi: 10.1002/hed.26468. Epub 2020 Sep 29.</citation>
    <PMID>32991009</PMID>
  </results_reference>
  <results_reference>
    <citation>Talevi V, Wen J, Lalla RV, Brennan MT, Mougeot FB, Mougeot JC. Identification of single nucleotide pleomorphisms associated with periodontal disease in head and neck cancer irradiation patients by exome sequencing. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020 Jul;130(1):32-42.e4. doi: 10.1016/j.oooo.2020.02.013. Epub 2020 May 22.</citation>
    <PMID>32451231</PMID>
  </results_reference>
  <results_reference>
    <citation>Mougeot JC, Stevens CB, Almon KG, Paster BJ, Lalla RV, Brennan MT, Mougeot FB. Caries-associated oral microbiome in head and neck cancer radiation patients: a longitudinal study. J Oral Microbiol. 2019 Mar 8;11(1):1586421. doi: 10.1080/20002297.2019.1586421. eCollection 2019.</citation>
    <PMID>30891159</PMID>
  </results_reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>February 5, 2014</study_first_submitted>
  <study_first_submitted_qc>February 5, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 7, 2014</study_first_posted>
  <last_update_submitted>September 27, 2021</last_update_submitted>
  <last_update_submitted_qc>September 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Atrium Health</investigator_affiliation>
    <investigator_full_name>Michael T. Brennan</investigator_full_name>
    <investigator_title>Michael Brennan, DDS, MHS</investigator_title>
  </responsible_party>
  <keyword>Head and Neck Cancer</keyword>
  <keyword>Radiation Therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Head and Neck Neoplasms</mesh_term>
    <mesh_term>Xerostomia</mesh_term>
    <mesh_term>Stomatognathic Diseases</mesh_term>
    <mesh_term>Osteoradionecrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

